SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.18 CNY | -0.28% |
|
+1.70% | -10.25% |
| 04-29 | Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-29 | RAAS Blood Products' 2023 Profit Falls 5% Despite 21% Revenue Growth | MT |
Evolution of the average Target Price on Shanghai RAAS Blood Products Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
cae43463f6610510a65c13e13dc.OvWuSbvXOwGoKEh6y9ZHLmOF3hUrMrM0Pxk1Hp4zKyQ.SJ_ke5awCkz_cng5guV_awLoh1FNYuxiWFNXad0EcXVPzPYw65h2R85jJw~b479d4e67f7677ac9f6bbb628e4f9d0f
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.18
CNY
Average target price
7
CNY
Spread / Average Target
-2.51%
High Price Target
7
CNY
Spread / Highest target
-2.51%
Low Price Target
7
CNY
Spread / Lowest Target
-2.51%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C-
EPS Revisions
- Stock Market
- Equities
- 002252 Stock
- Consensus Shanghai RAAS Blood Products Co., Ltd.
